Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
暂无分享,去创建一个
I. Shimomura | N. Maeda | S. Miyagawa | S. Fukushima | Y. Sawa | K. Toda | Nagako Sougawa | T. Kuratani | T. Ueno | R. Matsuura | D. Mori | K. Tomita
[1] H. Yim,et al. Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis , 2018, International journal of stem cells.
[2] Yuehua Wu,et al. Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms , 2017, Cardiovascular Diabetology.
[3] Y. van der Graaf,et al. Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials , 2017, Cardiovascular Diabetology.
[4] Ling Wei,et al. Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy , 2017, Chinese medical journal.
[5] T. Cahill,et al. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics , 2017, Nature Reviews Drug Discovery.
[6] T. Funahashi,et al. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2 , 2017, The Journal of Biological Chemistry.
[7] J. Boeynaems,et al. Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation. , 2017, Stem cells and development.
[8] T. Funahashi,et al. Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] J. Leor,et al. Macrophages and regeneration: Lessons from the heart. , 2016, Seminars in cell & developmental biology.
[10] S. Prabhu,et al. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.
[11] A. Sowińska,et al. The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression , 2016, PPAR research.
[12] I. Shimomura,et al. Adipose tissue macrophages induce PPARγ-high FOXP3+ regulatory T cells , 2015, Scientific Reports.
[13] R. de Caterina,et al. Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. , 2015, Cardiovascular research.
[14] A. J. Lusis,et al. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti‐inflammatory response , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] I. Shimomura,et al. Targeted delivery of adipocytokines into the heart by induced adipocyte cell-sheet transplantation yields immune tolerance and functional recovery in autoimmune-associated myocarditis in rats. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[16] T. Funahashi,et al. High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome , 2014, Cardiovascular Diabetology.
[17] S. Miyagawa,et al. Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy , 2013, BioMed research international.
[18] Abul Kashem,et al. Present status and future perspectives of heart transplantation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[19] Haiyun Huang,et al. The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair , 2013, PloS one.
[20] T. Funahashi,et al. Cardiovascular-metabolic impact of adiponectin and aquaporin. , 2013, Endocrine journal.
[21] P. Doevendans,et al. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. , 2013, Biochimica et biophysica acta.
[22] Meilian Liu,et al. Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. , 2012, Biochimie.
[23] Y. E. Chen,et al. PPARs and the cardiovascular system. , 2009, Antioxidants & redox signaling.
[24] N. Frangogiannis. The immune system and cardiac repair. , 2008, Pharmacological research.
[25] F. Prósper,et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction , 2008, European journal of heart failure.
[26] Francis G Spinale,et al. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.
[27] A. Schäffler,et al. Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies , 2007, Stem cells.
[28] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[29] Keith L. March,et al. Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.
[30] M. Matsuda,et al. Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.
[31] G. Goings,et al. T-cadherin Is a Major Glycophosphoinositol-anchored Protein Associated with Noncaveolar Detergent-insoluble Domains of the Cardiac Sarcolemma* , 1998, The Journal of Biological Chemistry.
[32] C M O'Connor,et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.
[33] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[34] T. Funahashi,et al. Cardiovascular-metabolic impact of adiponectin and aquaporin [Review] , 2013 .